Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News OraSure Technologies Inc OSUR

Healthcare Medical Instruments & Supplies
OraSure Technologies, Inc. provides point-of-care and home diagnostic tests, sample management solutions, and microbiome laboratory and analytical services. The Company's product portfolio is divided into diagnostics products and sample management solutions. Its business consists of the development, manufacture, marketing and sale of diagnostic products and specimen collection devices using its... see more

Recent & Breaking News (NDAQ:OSUR)

OraSure Receives $205 Million Procurement Contract for InteliSwab(TM) from the Defense Logistics Agency to Supply Over-the-Counter (OTC) Kits as Part of National Pandemic Response

GlobeNewswire September 20, 2021

OraSure Technologies Announces Resignation of CFO Roberto Cuca and Succession Plan

GlobeNewswire September 2, 2021

OraSure Technologies Reports 2Q21 Revenue of $57.6 Million Driven by Strong Rebound in Core Business

GlobeNewswire August 3, 2021

OraSure Technologies, Inc. to Hold 2021 Second Quarter Earnings Conference Call Tuesday, August 3, 2021, 5:00 p.m. ET

GlobeNewswire July 27, 2021

OraSure Technologies to Present at the Raymond James 2021 Human Health and Innovation Conference

GlobeNewswire June 17, 2021

OraSure and the Will Rodgers Liver Health Foundation to Heighten Awareness Around the Importance of Hepatitis C Testing

GlobeNewswire June 14, 2021

OraSure Technologies Receives Three Emergency Use Authorizations for its COVID-19 Rapid Antigen Tests for Non-Prescription (OTC), Professional and Prescription Use

GlobeNewswire June 7, 2021

OraSure Technologies to Present at the Jefferies Virtual Healthcare Conference

GlobeNewswire May 28, 2021

OraSure Technologies to Present at the UBS Global Healthcare Virtual Conference

GlobeNewswire May 18, 2021

OraSure Technologies Appoints Scott Gleason As Senior Vice President Investor Relations and Corporate Communications

GlobeNewswire May 17, 2021

OraSure Technologies to Hold Virtual Annual Meeting of Stockholders on May 18, 2021

GlobeNewswire May 12, 2021

Insignia and Partners Support CDC Demonstration Project for Uptake of Self-test Kits for HIV

GlobeNewswire May 10, 2021

OraSure Technologies, Inc. Announces First Quarter 2021 Financial Results and Provides COVID-19 Update

GlobeNewswire May 5, 2021

OraSure Technologies to Hold 2021 First Quarter Earnings Conference Call Wednesday, May 5, 2021, 5:00 p.m. ET

GlobeNewswire April 30, 2021

OraSure Technologies Submits COVID-19 Rapid Antigen Prescription Home Self-Test and Professional Test to FDA for Emergency Use Authorization

GlobeNewswire March 30, 2021

OraSure Technologies, Inc. Announces 2020 Full-Year and Fourth Quarter Financial Results and Provides COVID-19 Update

GlobeNewswire March 1, 2021

OraSure Technologies to Present at the Raymond James 42nd Annual Institutional Investors Conference

GlobeNewswire February 24, 2021

2020 Fourth Quarter Earnings Conference Call Monday, March 1, 2021, 5:00 p.m. ET

GlobeNewswire February 18, 2021

OraSure Subsidiary DNA Genotek's OMNIgene®·ORAL Included in EUA Granted to Ambry Genetics for Use in COVID-19 RT-PCR Saliva Test

GlobeNewswire January 29, 2021

OraSure Subsidiary DNA Genotek's OMNIgene®·ORAL Saliva Collection Device Receives Health Canada Authorization for use in COVID-19 Testing

GlobeNewswire January 28, 2021